(firstQuint)Immunogenicity and Safety of a Purified Vero Rabies Vaccine.

 This study will assess different formulations of the modified formulation of VRVg (VRVg 2) to be tested in parallel to the initial VRVg formulation (VRVg 1) and Imovax rabies.

 Immune responses will be assessed at Day 14, Day 28, Day 42, and at Month 7.

 Safety events will also be reported.

.

 Immunogenicity and Safety of a Purified Vero Rabies Vaccine@highlight

This multicenter, observer-blind, controlled, randomized, Phase II study was designed to evaluate different formulations of the Purified Vero Rabies Cell vaccine VRVg.

